Harbor Healthcare Advises La Vita Compounding On Its Sale & Strategic Partnership

San Diego, November 2023 – La Vita Compounding Pharmacy, a trusted 503A compounding pharmacy, is proud to announce its acquisition by a strategic buyer. The acquisition comes as part of the buyer’s strategic vision to build a national platform in the compounding pharmacy industry, leveraging the expertise and reputation of La Vita as they expand […]

2023 LTC Pharmacy Market Update – How Inflation and Marginalized Patients Will Impact Values in The Coming Years

LTC Pharmacy underwent more disruption and change in just the past few years than the preceding decades. Revenue models morphed, strategies reversed, and service transformed. The M&A landscape is now replete with both private equity-backed and independent operators scooping up quality businesses. At the same time, LTC facility M&A is speeding up after a slow […]

Healthcare M&A Valuations Expected To Remain Strong In 2023 Despite Uncertainty

The healthcare services sector continues to attract attention from buyers across a broad range of backgrounds. While late 2021 and 2022 proved to be record years for healthcare M&A, 2023 is expected to descend slightly, but still land above pre-pandemic levels. The industry’s overall strengths will endure, people need care, drugs, and medical devices in […]

Harbor Healthcare Advises 5,100 Resident LTC Pharmacy On Its Sale & Partnership

Harbor Healthcare is pleased to announce the successful sale of a Southern California based long-term care pharmacy, servicing over 5,100 licensed assisted living and group home patients. The strategic acquirer maintains a nationwide presence in the long-term care space and this acquisition provides them with further penetration into the highly competitive Southern California market. The […]

How Economic Uncertainty Will Impact Pharmacy Valuations in 2023

Harbor Healthcare Advises Hopkinton Drug Compounding On Its Sale & Strategic Partnership

Harbor Healthcare Consultants is pleased to announce the successful sale of Hopkinton Drug Compounding Pharmacy, a Massachusetts-based 503A compounding pharmacy and leading provider of compounded therapies serving patients across 35 states. The transaction brings together two independent pharmacies and creates tremendous value for both buyer and seller. Combining their geographic footprints, the acquiring pharmacy will […]

Harbor Healthcare Advises 8,500 Patient California Long-Term Care Pharmacy On Its Sale & Strategic Partnership

California, October 2022 – Harbor Healthcare is pleased to announce the successful sale of a multi-location long-term care (LTC) pharmacy, servicing over 8,500 patients in skilled nursing facilities throughout the state of California. The strategic acquirer maintains a nationwide presence in the LTC pharmacy space, and this acquisition provides them with key access to the […]

Harbor Healthcare Advises Custom Rx Compounding Pharmacy On Its Sale

Midwest, September 2022 – Harbor Healthcare Consultants is pleased to announce the successful sale of Custom Rx 503A compounding pharmacy serving patients across 42 states with annualized profits in excess of $5 million. The transaction brings together two prominent pharmacies with extensive synergies creating tremendous value to both parties. Compounding pharmacy is a highly competitive […]

Harbor Healthcare Advises Pharmacy Solutions 503A Compounding Pharmacy On Its Sale

Michigan, March 2022 – Harbor Healthcare Consultants is pleased to announce the successful sale of Pharmacy Solutions, a Michigan-based 503A compounding pharmacy and leading provider of compounded therapies serving patients across 43 states. The transaction brings together two prominent pharmacies with extensive synergies and creates tremendous value for both buyer and seller. Building on their […]

2022 Compounding Pharmacy Market Outlook

What’s driving the interest in compounding pharmacy? Disruption, growth and industry architecture. First, acquirers are aggressively seeking to establish boots on the ground in all 50 states. Even though the FDA conceded on the MOU1, brick-and-mortar presence is crucial for a nationwide strategy. Second, telehealth is creating new revenue channels for compounding pharmacy by expanding […]

A much deserved yet overdue thank you for your continued help and support of me with the questions that I ask of you from time to time. I appreciate your patience and perseverance in ensuring that you find the right answer for me.
Jeffrey E. Feldberg
Choosing someone that could mentor me with all of the nuances of this type of business was important. I was very fortunate to find Mark who has been instrumental in helping me understand not only what needed to be done but also how to accomplish it in the most effective, efficient way.
Tammy Miller
Being a pharmacist himself and owning his own businesses provides Ira with unique insight when working on behalf of a pharmacy owner… While working on my behalf, I observed several of Ira’s personality characteristics which helped create and keep the deal together; these being: people skills, positive attitude, decisiveness, creativity and intellect. In addition, during the transaction Ira was able to gain the respect of our prospective buyers with his expertise and style…
Ronald A. Memo, RPh
Ira Cammeyer is not a “business broker”. He and his colleagues are deal makers. They maximize your position in the market and represent you 110%. The association does not stop after the deal is done. Belonging to the “Ira” family brings you opportunities in the future. In addition, Ira is there for you. His opinion and network is just a phone call away.
Stanley R. Goldenberg, RPh, FASCP
Michael worked tirelessly in establishing financials that would convert our private business records into the format required for evaluation by potential capital partners. We could not be more pleased by the results and will continue our relationship with Harbor Healthcare so that they can assist us in finding potential acquisition targets.
Ron Belville, RPh